Jan 25 (Reuters) - Shenyang Xingqi Pharmaceutical Co Ltd :
* Sees net profit for FY 2017 to decrease by 20.8 percent to 28.4 percent, compared to net profit of FY 2016 (54.3 million yuan)
* Says decreased combined gross profit rate and increased R&D cost as main reasons for the forecast
Source text in Chinese: goo.gl/sSpMd9
Further company coverage: (Beijing Headline News)
 